Yvet Noordman

Head of Pharmaceutical Development at LinXis Biopharmaceuticals
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
NL

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Netherlands
    • Biotechnology Research
    • 1 - 100 Employee
    • Head of Pharmaceutical Development
      • Jan 2023 - Present

    • Netherlands
    • Biotechnology
    • 1 - 100 Employee
    • Director Analytical development
      • Mar 2021 - Dec 2022

    • Principal Scientist Analytical Development
      • Jan 2020 - Feb 2021

    • Senior Scientist Analytical Development and Quality Control
      • May 2018 - Dec 2019

    • Netherlands
    • Biotechnology Research
    • 400 - 500 Employee
    • Senior Scientist Analytical Development/Team Lead Product Support
      • Jan 2014 - Apr 2018

      o Supervision Scientists and Technicians Analytical Development, Product support groupo Method development, qualification and reporting of analytical packages supporting AAV-based product release testing o Reference standard qualificationo Master and Working Cell bank and Viral Seeds qualificationo Phase I/II product release and stability testing, support QP releaseo Setting product specificationso Extended product characterization (Phase I/II, Phase III and commercial products)o Product comparability (Phase I/II, Phase III and commercial products)o Assay validation according ICH Q2o Assay trouble shooting o Contribution to Module 3 of IND/IMPD and MAA dossierso Assay transfer to Quality Control department uniQure Lexington facilityo AD Lead Scientist in multi-disciplinary CMC project teams

    • Scientist Analytical Development
      • Nov 2010 - Dec 2013

      o Responsible for the development of molecular biological assays (e.g. qPCR, PCR and gel based assays) o Setup assay validation strategies for Q-PCR methods according to ICH guidelineo Manage development of molecular biological assays at CRO o Additional (non-routine) characterization of rAAV products o Contribution to registration dossier (CMC section)o Manage assay transfer activities to Quality Control departmento Reference standards

    • Scientist Vector Development
      • Mar 2007 - Nov 2010

      o Main focus to improve baculovirus-based rAAV production process using directed protein evolution and molecular biological approacheso rAAV product characterization using molecular biological and biochemical methodso Contribution to registration dossier (CMC section)

    • Netherlands
    • Hospitals and Health Care
    • 700 & Above Employee
    • Ph D student
      • Oct 2002 - Oct 2006

      o Subject: Protein tyrosine phosphatase PTPRR isoforms function as multimeric brain-specific MAPK phosphatases o Techniques: Tissue culture, transfections, retroviral transduction, pull-down assays, co-immunoprecipitations, SDS-PAGE, quantitative Western blotting (Odyssey infrared imaging system), RT-PCR, PCR, cloning, site directed mutagenesis, RNA interference, immunohistochemistry, immunofluorescence and confocal laser scanning microscopy. o Subject: Protein tyrosine phosphatase PTPRR isoforms function as multimeric brain-specific MAPK phosphatases o Techniques: Tissue culture, transfections, retroviral transduction, pull-down assays, co-immunoprecipitations, SDS-PAGE, quantitative Western blotting (Odyssey infrared imaging system), RT-PCR, PCR, cloning, site directed mutagenesis, RNA interference, immunohistochemistry, immunofluorescence and confocal laser scanning microscopy.

Education

  • Radboud University
    MSc, Chemistry
    1997 - 2002
  • Geert Groote College
    Atheneum
    1992 - 1997

Community

You need to have a working account to view this content. Click here to join now